Wonder Club world wonders pyramid logo
×

Stability Of Protein Pharmaceuticals, Part B Book

Stability Of Protein Pharmaceuticals, Part B
Stability Of Protein Pharmaceuticals, Part B, Part B explores protein degradation occuring in vivo during protein synthesis in cells, examines the isolation and purification of proteins, details protein use in organisms, and reviews techniques to enhance protein stability., Stability Of Protein Pharmaceuticals, Part B has a rating of 4 stars
   2 Ratings
X
Stability Of Protein Pharmaceuticals, Part B, Part B explores protein degradation occuring in vivo during protein synthesis in cells, examines the isolation and purification of proteins, details protein use in organisms, and reviews techniques to enhance protein stability., Stability Of Protein Pharmaceuticals, Part B
4 out of 5 stars based on 2 reviews
5
0 %
4
100 %
3
0 %
2
0 %
1
0 %
Digital Copy
PDF format
1 available   for $258.24
Original Magazine
Physical Format

Sold Out

  • Stability Of Protein Pharmaceuticals, Part B
  • Written by author Tim J. Ahern
  • Published by Springer-Verlag New York, LLC, November 1992
  • Part B explores protein degradation occuring in vivo during protein synthesis in cells, examines the isolation and purification of proteins, details protein use in organisms, and reviews techniques to enhance protein stability.
  • Genetics Institute, Inc., Cambridge, Massachusetts. Pharmaceutical Biotechnology, Volume 3. Second part of two-part set. Deals with in vivo degradation and methods designed to enhance protein stability. Booknews See preceding entry. Part B
Buy Digital  USD$258.24

WonderClub View Cart Button

WonderClub Add to Inventory Button
WonderClub Add to Wishlist Button
WonderClub Add to Collection Button

Book Categories

Authors

Improper Glycosylation and the Cellular Editing of Nascent Proteins; D.A. Cumming. Protein Aggregation In Vivo; R. Wetzel. Pathways of Intracellular Protein Degradation in Eukaryotic Cells; T.S. Olson, et al. Effects of Aging on Proteins; R.W. Gracy. Engineering Dramatic Increases in the Stability of Subtilisin; P.N. Bryan. Increased Stability of Mutant Forms of Yeast Cyhrome c; D.R. Hickey, et al. Introduction to Formulation of Protein Pharmaceuticals; M.A. Hanson, S.K.E. Rouan. PEG Modified Proteins; G.E. Francis, et al. Stabilization of Protein Structure by Solvent Additives; S.N. Timasheff. Heat-Shock Proteins and their Potential Uses for Pharmaceutical Protein Production in Microorganisms; J.M. McCoy. Index.


Login

  |  

Complaints

  |  

Blog

  |  

Games

  |  

Digital Media

  |  

Souls

  |  

Obituary

  |  

Contact Us

  |  

FAQ

CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!!

X
WonderClub Home

This item is in your Wish List

Stability Of Protein Pharmaceuticals, Part B, Part B explores protein degradation occuring in vivo during protein synthesis in cells, examines the isolation and purification of proteins, details protein use in organisms, and reviews techniques to enhance protein stability., Stability Of Protein Pharmaceuticals, Part B

X
WonderClub Home

This item is in your Collection

Stability Of Protein Pharmaceuticals, Part B, Part B explores protein degradation occuring in vivo during protein synthesis in cells, examines the isolation and purification of proteins, details protein use in organisms, and reviews techniques to enhance protein stability., Stability Of Protein Pharmaceuticals, Part B

Stability Of Protein Pharmaceuticals, Part B

X
WonderClub Home

This Item is in Your Inventory

Stability Of Protein Pharmaceuticals, Part B, Part B explores protein degradation occuring in vivo during protein synthesis in cells, examines the isolation and purification of proteins, details protein use in organisms, and reviews techniques to enhance protein stability., Stability Of Protein Pharmaceuticals, Part B

Stability Of Protein Pharmaceuticals, Part B

WonderClub Home

You must be logged in to review the products

E-mail address:

Password: